Understanding the role of NRF2-regulated miRNAs in human malignancies

Niraj M. Shah; Stuart Rushworth; Megan A. Murray; Kristian M. Bowles; David J. MacEwan

doi:10.18632/oncotarget.1181

Understanding the role of NRF2-regulated miRNAs in human malignancies

Niraj M. Shah, Stuart Rushworth, Megan A. Murray, Kristian M. Bowles, David J. MacEwan

Research output: Contribution to journal › Article › peer-review

52 Citations (Scopus)

Abstract

Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a key transcription factor that regulates the expression of over a hundred cytoprotective and antioxidant genes that provide cellular protection from reactive oxygen species. Chemotherapy resistance in several cancers has been linked to dysregulation of the NRF2 signalling pathway, moreover there is growing evidence that NRF2 may contribute to tumorigenesis. MicroRNA (miRNA) are small non-coding RNA sequences that post-transcriptionally regulate mRNA sequences. In cancer pathogenesis, aberrantly expressed miRNAs can act as either tumor suppressor or oncogenic miRNA. Recent evidence has been described that identifies a number of miRNA that can be regulated by NRF2. This review outlines the importance of NRF2 in regulating miRNA, and the functional role this may have in the tumorigenesis of human malignancies and their chemotherapy resistance.

Original language	English
Pages (from-to)	1130-1142
Number of pages	13
Journal	Oncotarget
Volume	4
Issue number	8
DOIs	https://doi.org/10.18632/oncotarget.1181
Publication status	Published - 8 Aug 2013

Access to Document

10.18632/oncotarget.1181Licence: CC BY

Cite this

@article{2a25fff3ec0345c3ac2b00854dba30dd,

title = "Understanding the role of NRF2-regulated miRNAs in human malignancies",

abstract = "Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a key transcription factor that regulates the expression of over a hundred cytoprotective and antioxidant genes that provide cellular protection from reactive oxygen species. Chemotherapy resistance in several cancers has been linked to dysregulation of the NRF2 signalling pathway, moreover there is growing evidence that NRF2 may contribute to tumorigenesis. MicroRNA (miRNA) are small non-coding RNA sequences that post-transcriptionally regulate mRNA sequences. In cancer pathogenesis, aberrantly expressed miRNAs can act as either tumor suppressor or oncogenic miRNA. Recent evidence has been described that identifies a number of miRNA that can be regulated by NRF2. This review outlines the importance of NRF2 in regulating miRNA, and the functional role this may have in the tumorigenesis of human malignancies and their chemotherapy resistance.",

author = "Shah, {Niraj M.} and Stuart Rushworth and Murray, {Megan A.} and Bowles, {Kristian M.} and MacEwan, {David J.}",

year = "2013",

month = aug,

day = "8",

doi = "10.18632/oncotarget.1181",

language = "English",

volume = "4",

pages = "1130--1142",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "8",

}

TY - JOUR

T1 - Understanding the role of NRF2-regulated miRNAs in human malignancies

AU - Shah, Niraj M.

AU - Rushworth, Stuart

AU - Murray, Megan A.

AU - Bowles, Kristian M.

AU - MacEwan, David J.

PY - 2013/8/8

Y1 - 2013/8/8

N2 - Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a key transcription factor that regulates the expression of over a hundred cytoprotective and antioxidant genes that provide cellular protection from reactive oxygen species. Chemotherapy resistance in several cancers has been linked to dysregulation of the NRF2 signalling pathway, moreover there is growing evidence that NRF2 may contribute to tumorigenesis. MicroRNA (miRNA) are small non-coding RNA sequences that post-transcriptionally regulate mRNA sequences. In cancer pathogenesis, aberrantly expressed miRNAs can act as either tumor suppressor or oncogenic miRNA. Recent evidence has been described that identifies a number of miRNA that can be regulated by NRF2. This review outlines the importance of NRF2 in regulating miRNA, and the functional role this may have in the tumorigenesis of human malignancies and their chemotherapy resistance.

AB - Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a key transcription factor that regulates the expression of over a hundred cytoprotective and antioxidant genes that provide cellular protection from reactive oxygen species. Chemotherapy resistance in several cancers has been linked to dysregulation of the NRF2 signalling pathway, moreover there is growing evidence that NRF2 may contribute to tumorigenesis. MicroRNA (miRNA) are small non-coding RNA sequences that post-transcriptionally regulate mRNA sequences. In cancer pathogenesis, aberrantly expressed miRNAs can act as either tumor suppressor or oncogenic miRNA. Recent evidence has been described that identifies a number of miRNA that can be regulated by NRF2. This review outlines the importance of NRF2 in regulating miRNA, and the functional role this may have in the tumorigenesis of human malignancies and their chemotherapy resistance.

U2 - 10.18632/oncotarget.1181

DO - 10.18632/oncotarget.1181

M3 - Article

VL - 4

SP - 1130

EP - 1142

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 8

ER -